Long-term heavy marijuana users make costly decisions on a gambling task

Drug and Alcohol Dependence
Christopher T WhitlowLinda Porrino

Abstract

Chronic marijuana use has been associated with impairments of learning, memory, and executive functions. Little is known, however, about the effects of marijuana use on other cognitive domains, such as decision-making, which are thought to play an important role in addiction and drug abuse. The purpose of the present study was to determine if long-term heavy marijuana users employ different decision-making strategies than individuals with minimal marijuana exposure. Volunteers were assigned to a cannabis (n = 10) or control group (n = 10) based upon history of prior marijuana use. Demographic and neuropsychological variables were evaluated, and a decision-making task--the gambling task (GT) was administered. Although few demographic and neuropsychological differences were noted between groups, marijuana users made more decisions that led to larger immediate gains despite more costly losses than controls. These data suggest that long-term heavy marijuana users may have specific deficits in the ability to balance rewards and punishments that may contribute to continued drug-taking behavior. It is unknown, however, whether the basis for such deficits might be attributed directly to marijuana exposure or pre-existing genetic or beh...Continue Reading

References

Apr 1, 1995·Drug and Alcohol Dependence·H G PopeD Yurgelun-Todd
Nov 1, 1996·Archives of General Psychiatry·J M FletcherP Satz
Sep 1, 1997·Pharmacology, Biochemistry, and Behavior·S J HeishmanM L Stitzer
Aug 12, 1998·The American Journal of Psychiatry·K S Kendler, C A Prescott
Mar 25, 1999·Psychopharmacology·M HaneyM W Fischman
Apr 30, 1999·American Journal of Epidemiology·C G LyketsosJ C Anthony
Aug 25, 1999·Psychopharmacology·H C MiddletonT W Robbins
Jan 14, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·G BartzokisE D London
Aug 3, 2000·Alcoholism, Clinical and Experimental Research·C A MazasJ E Steinmetz
Nov 1, 2001·Archives of General Psychiatry·H G PopeD Yurgelun-Todd
Nov 15, 2001·Current Psychiatry Reports·H G PopeD Yurgelun-Todd
Mar 7, 2002·JAMA : the Journal of the American Medical Association·Nadia SolowijUNKNOWN Marijuana Treatment Project Research Group
May 7, 2002·Psychological Medicine·K S KendlerR C Kessler
Aug 21, 2003·Drug and Alcohol Dependence·Christopher T WhitlowLinda J Porrino
Aug 29, 2003·Journal of Abnormal Psychology·Alan J BudneyJohn R Hughes

❮ Previous
Next ❯

Citations

Jan 21, 2006·Psychopharmacology·Boris B QuednowMichael Wagner
Nov 10, 2012·Psychopharmacology·Donald M DoughertyAshley Acheson
Jan 31, 2008·Cognitive Processing·Matthias BrandHans J Markowitsch
Feb 6, 2009·Neuropsychology Review·Melissa T Buelow, Julie A Suhr
Aug 15, 2006·Journal of the International Neuropsychological Society : JINS·Antonio Verdejo-GarcíaMiguel Pérez-García
Aug 22, 2013·Journal of the International Neuropsychological Society : JINS·Natania A CraneRaul Gonzalez
Jun 8, 2006·Experimental and Clinical Psychopharmacology·Scott D LaneJerome R Busemeyer
Aug 9, 2006·Experimental and Clinical Psychopharmacology·Richard YiWarren K Bickel
Oct 1, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jatin G VaidyaAntoine Bechara
Sep 29, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Robert D RogersPetra Makela
Nov 2, 2013·Journal of Psychoactive Drugs·Delroy A JeffersonAnne Jackson-Gibson
Mar 17, 2007·Journal of Clinical and Experimental Neuropsychology·Raul GonzalezEileen M Martin
Apr 10, 2009·Journal of Clinical and Experimental Neuropsychology·Matthias BrandHans J Markowitsch
Mar 24, 2012·Journal of Clinical and Experimental Neuropsychology·Merel F H Griffith-LenderingHanna Swaab
Jan 1, 2011·ILAR Journal·Divya RameshAron H Lichtman
Feb 16, 2011·Journal of Addiction Medicine·Rebecca D CreanBarbara J Mason
Jun 3, 2008·Journal of Psychopharmacology·L ClarkB J Sahakian
Jun 10, 2010·PloS One·Byoung Woo KimUNKNOWN Phenotype Genotype Project in Addiction and Mood Disorders (PGP)
Aug 21, 2013·Journal of Addiction·Jennifer Tropp SneiderDeborah A Yurgelun-Todd
Apr 21, 2006·Expert Review of Neurotherapeutics·Catherine M CahillMartin Cohen
Aug 26, 2010·Pharmaceuticals·Marco BortolatoSimone Tambaro
Jul 2, 2010·Substance Use & Misuse·Valentina LorenzettiMurat Yücel
Feb 10, 2016·Biological Psychiatry·Samantha J BroydNadia Solowij
Mar 10, 2015·Addictive Behaviors·Zoe BriggsRobert Whelan
Jul 28, 2012·Psychiatry Research·Melissa P Lopez-LarsonDeborah A Yurgelun-Todd
Jan 26, 2011·Journal of Psychosomatic Research·Amy BroganDonal O'Shea
Apr 24, 2010·Psychiatry Research·Krista Lisdahl MedinaSusan F Tapert
Apr 1, 2010·Experimental Neurology·Liana FattoreWalter Fratta
Apr 27, 2010·Journal of Mathematical Psychology·Daniel J FridbergJulie C Stout
Nov 14, 2008·Journal of Substance Abuse Treatment·Scott M Hyman, Rajita Sinha
Aug 30, 2008·Neuropharmacology·Antonio Verdejo-García, Antoine Bechara

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.